Pharmacological Intervention of Cyclooxygenase-2 and 5-Lipoxygenase Pathways. Impact on Inflammation and Cancer

By  

Current Pharmaceutical Design, Vol. 11, Iss. 26, 2005-10 ,pp. : 3431-3447

Bentham Science Publishers

Access to resources Recommend Favorite

The pharmacological profile of ML3000: A new pyrrolizine derivative inhibiting the enzymes cyclo-oxygenase and 5-lipoxygenase

By Tries S.  

Inflammopharmacology, Vol. 9, Iss. 1-2, 2001-05 ,pp. : 113-124

VSP

Access to resources Recommend Favorite

New Insights into Molecular Mechanisms of Atrial Fibrillation: Are We Approaching Possible Novel Pharmacological Principles for Treating This Disorder?

By  

Heart Drug, Vol. 3, Iss. 4, 2004-02 ,pp. : 180-190

Karger

Access to resources Recommend Favorite

Cicletanine New insights into its pharmacological actions

By Kalinowski L.   Szczepanska-Konkel M.x.   Jankowski M.   Angielski S.  

General Pharmacology, Vol. 33, Iss. 1, 1999-07 ,pp. : 7-16

Elsevier

Access to resources Recommend Favorite

Mitophagy and Disease: New Avenues for Pharmacological Intervention

By  

Current Pharmaceutical Design, Vol. 17, Iss. 20, 2011-07 ,pp. : 2056-2073

Bentham Science Publishers

Access to resources Recommend Favorite